Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Search

Announcements

Subscribe to investor news

Investor News

BioPorto

BioPorto A/S

Correction: Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S

Tue, 15 Apr 2025 06:31 GMT

BioPorto

BioPorto A/S

Correction: Rettet emission af 25.000.000 nye aktier fuldt tegnet – bruttoprovenu på 33,5 mio. kr. til BioPorto A/S

Tue, 15 Apr 2025 06:31 GMT

BioPorto

BioPorto A/S

Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S

Tue, 15 Apr 2025 06:15 GMT

BioPorto

BioPorto A/S

Rettet emission af 25.000.000 nye aktier fuldt tegnet – bruttoprovenu på 33,5 mio. kr. til BioPorto A/S

Tue, 15 Apr 2025 06:15 GMT

BioPorto

BioPorto A/S

BioPorto A/S initiates a private placement of up to 25,000,000 new shares at market price. The Board of Directors has received advance indications for the full offering which is expected to raise proceeds of DKK 33.5 million.

Mon, 14 Apr 2025 14:55 GMT

Follow this link to view all historical announcements.